Information Journal Paper
APA:
Copy. (2018). Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil. JOURNAL OF CANCER, 9(16), 2765-2772. SID. https://sid.ir/paper/775892/en
Vancouver:
Copy. Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil. JOURNAL OF CANCER[Internet]. 2018;9(16):2765-2772. Available from: https://sid.ir/paper/775892/en
IEEE:
Copy, “Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil,” JOURNAL OF CANCER, vol. 9, no. 16, pp. 2765–2772, 2018, [Online]. Available: https://sid.ir/paper/775892/en